B-Cell Directed Therapy for Chronic GVHD

Track: BMT Tandem "Scientific" Meeting
Friday, February 13, 2015, 8:30 AM-10:00 AM
Seaport A-E (Manchester Grand Hyatt)
Corey S. Cutler, MD , Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Disclosures:
C. S. Cutler, Takeda, Advisor: Consultancy
Pharmacyclics, Advisor: Consultancy
Fate , Advisor: Advisory Board
Idera, Advisor: Advisory Board
<< Previous Presentation | Next Presentation